2,904
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models

, , , , , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Article: e1539613 | Received 11 Jun 2018, Accepted 04 Oct 2018, Published online: 20 Nov 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.